# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028551
Filing Date
2022-11-07
Accepted
2022-11-07 08:48:15
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrsn-20220930.htm iXBRL | 10-Q | 1628254
2 | EX-10.1 | exhibit101.htm | EX-10.1 | 1260299
3 | EX-31.1 | exhibit31110-qfy2022q3.htm | EX-31.1 | 11206
4 | EX-31.2 | exhibit31210-qfy2022q3.htm | EX-31.2 | 11170
5 | EX-32.1 | exhibit32110-qfy2022q3.htm | EX-32.1 | 5806
| Complete submission text file | 0001628280-22-028551.txt |  | 7759430

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrsn-20220930.xsd | EX-101.SCH | 39610
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrsn-20220930_cal.xml | EX-101.CAL | 46477
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrsn-20220930_def.xml | EX-101.DEF | 198041
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrsn-20220930_lab.xml | EX-101.LAB | 494716
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrsn-20220930_pre.xml | EX-101.PRE | 339020
62 | EXTRACTED XBRL INSTANCE DOCUMENT | mrsn-20220930_htm.xml | XML | 942288

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 221363890
SIC: 2834 Pharmaceutical Preparations